Covid-19 Vaccine, produced by AstraZeneca Pharmaceutical Company and Oxford University, has been 79% effective in a US test. In this way, the AstraZeneca-Oxford Covid-19 vaccine may soon be approved for use by the US administration. It is worth noting that in recent times, there were cases of blood clotting (blood clotting) after the introduction of the AstraZeneca vaccine. After this, its use was banned in many countries.
The British pharmaceutical company on Monday published the data of a study conducted on 30,000 volunteers. The vaccine results are good news for the elderly, as a quarter of the volunteers included in the trial were over 65 years of age. Earlier, due to non-inclusion of less than 65 years of age in the study conducted last year, the data obtained from it failed to give a conclusive result. This vaccine prepared by AstraZeneca-Oxford has been 100 percent effective in preventing the rate of serious illness, death and hospitalization.
Use of the vaccine in many countries stopped due to cases of blood clotting
After these results are revealed, the reliability of the vaccine will increase worldwide. Recently, questions were raised about the reliability and efficacy of the vaccine due to cases of blood clotting. In particular, many countries of Europe had banned its use due to cases of blood clotting. Although the AstraZeneca vaccine has been approved for use in more than 50 countries around the world, it has not yet been approved for use in the United States.
Britain was first approved to use the vaccine
Britain had approved the use of the vaccine on the basis of partial results of the vaccine in Brazil, South Africa and its country. It was told that the vaccine is up to 70 percent effective. After this, questions were raised about the efficacy of this vaccine on the elderly. European countries such as Germany, France and Belgium advised not to plant it among the elderly. At the same time, after the test results surfaced about senior citizens, it was approved for use.
Blood clot stopped vaccine use in many countries
Last week, a dozen countries, including many countries in Europe, banned the use of the AstraZeneca vaccine after cases of blood clots surfaced. On Thursday, after an investigation by the European Medicine Agency concluded that the vaccine is not at risk of the blood clot. After this, France, Germany, Italy and other countries resumed their use of the vaccine from Friday. Some senior leaders of the country certified the safety of the vaccine by installing it.
Also read: Foreign journalists whom China did not even tolerate, now Corona vaccine is going to be installed